You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
MBS has developed a compact endpoint PCR system which can test more than 22,000 patient samples per day by performing eight-minute thermal cycling.
The kit is designed to detect the RdRP gene, E gene, and N gene of the virus and runs on all major thermocyclers.
The newly independent firm will continue to invest in diagnostics by bringing its menu of PCR tests for infectious diseases to the US and other markets, among other objectives.